Polymorphs of clopidogrel hydrogensulfate

Details for Australian Patent Application No. 2008202343 (hide)

International Classifications

Event Publications

12 June 2008 Complete Application Filed

19 June 2008 Application Open to Public Inspection

Published as AU-A-2008202343

10 July 2008 Section 223 Application Received

Teva Pharmaceutical Industries Ltd. An application to extend the time from 14 Sep 2007 to 14 Jun 2008 in which to make a further application for a divisional patent has been filed . Address for service in Australia - Shelston IP 60 Margaret Street SYDNEY NSW 2000

28 August 2008 Section 223 Application Allowed

Teva Pharmaceutical Industries Ltd. The time in which to make a further application for a divisional patent has been extended to 14 Jun 2008. Address for service in Australia - Shelston IP 60 Margaret Street Sydney NSW 2000

29 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.